Clinical and immunological manifestations of patients with atypical severe combined immunodeficiency

Clin Immunol. 2011 Oct;141(1):73-82. doi: 10.1016/j.clim.2011.05.007. Epub 2011 May 30.

Abstract

Hypomorphic mutations in genes associated with severe combined immunodeficiency (SCID) or Omenn syndrome can also cause milder immunodeficiencies. We report 10 new patients with such "atypical" SCID and summarize 63 patients from the literature. The patient groups with T(low)B(low) (n=28), T(low)B(+) (n=16) and ADA (n=29) SCID variants had similar infection profiles but differed in the frequency of immune dysregulation, which was observed predominantly in patients with recombination defects. Most immunological parameters were remarkably similar in the three groups. Of note, 19/68 patients with "atypical" SCID had normal T cell counts, 48/68 had normal IgG and 23/46 had at least one normal specific antibody titer. Elevated IgE was a characteristic feature of ADA deficiency. This overview characterizes "atypical" SCID as a distinct disease with immune dysregulation in addition to infection susceptibility. Lymphopenia, reduced naïve T cells and elevated IgE are suggestive, but not consistent features of the disease.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adenosine Deaminase / deficiency
  • Adenosine Deaminase / genetics
  • Adenosine Deaminase / immunology
  • Adolescent
  • Adult
  • Agammaglobulinemia / complications
  • Agammaglobulinemia / genetics
  • Agammaglobulinemia / immunology
  • Autoimmune Diseases / complications
  • Autoimmune Diseases / genetics
  • Autoimmune Diseases / immunology
  • B-Lymphocytes / immunology
  • Child
  • Child, Preschool
  • Cohort Studies
  • Humans
  • Immunoglobulin E / blood
  • Infant, Newborn
  • Infections / etiology
  • Mutation
  • Severe Combined Immunodeficiency / complications
  • Severe Combined Immunodeficiency / genetics
  • Severe Combined Immunodeficiency / immunology*
  • Severe Combined Immunodeficiency / therapy
  • T-Lymphocytes / immunology
  • Treatment Outcome

Substances

  • Immunoglobulin E
  • Adenosine Deaminase

Supplementary concepts

  • Severe combined immunodeficiency due to adenosine deaminase deficiency
  • Severe combined immunodeficiency, atypical